Catalyst Pharmaceuticals Announces Second Quarter 2016 Financial Results and Provides Product Development Update

Go back to Catalyst Pharmaceuticals Announces Second Quarter 2016 Financial Results and Provides Product Development Update
Catyalyst Pharmaceutical Partners, Inc. (NASDAQ: CPRX) Delayed: 31.45 +0.01 (0.03%)
Previous Close $31.44    52 Week High $3.00 
Open $31.45    52 Week Low $0.51 
Day High $31.47    P/E N/A 
Day Low $31.44    EPS $-0.25 
Volume 1,616,291